Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Up until recently, the drugs have been FDA-approved only for weight loss or diabetes, and insurance coverage has been patchy
4% with placebo, and vomiting (5%, 7% and 14%) vs
symptom management and orthotic support AFO for foot drop (L-code orthoses), custom footwear, surgery for foot deformity (pes cavus correction) Genetic counseling: document gene mutation identified (PMP22 duplication CMT1A, GJB1 CMTX, MFN2 CMT2A) Avoid neurotoxic drugs (vincristine, colchicine) document CMT diagnosis prominently in medication reconciliation Patient Education / Summary Patient education documentation supports coding specificity and demonstrates active management of neuropathy complications
Problems were not found among standard creatine "powder" products
US$ 27.09
US$ 20.28
US$ 29.95
US$ 27.71
US$ 21.36
US$ 22.27
US$ 29.00
